4.6 Article

Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 34, Issue 8, Pages 1292-1300

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfz026

Keywords

malignancy; pretransplant evaluation; transplantation; waiting list; waiting time

Funding

  1. ERA-EDTA

Ask authors/readers for more resources

Current proposals for waiting times for a renal transplant after malignant disease may not be appropriate. New data on malignancies in end-stage renal disease and recent diagnostic and therapeutic options should lead us to reconsider our current practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

What matters to you?: The relevance of patient priorities in dialysis care for assessment and clinical practice

Judith Tommel, Andrea W. M. Evers, Henk W. van Hamersvelt, Rien Jordens, Sandra van Dijk, Luuk B. Hilbrands, Marc M. H. Hermans, Daan A. M. J. Hollander, Jos J. van de Kerkhof, Marc A. G. J. ten Dam, Henriet van Middendorp

Summary: The study aimed to identify dialysis patients' most prominent problems and calculate disease-specific norms for questionnaires measuring these problems. Results showed that fatigue was the most prominent problem, and patient priorities and functioning domains differed based on patient characteristics.

SEMINARS IN DIALYSIS (2023)

Article Immunology

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

Jan Stephan F. Sanders, A. Lianne Messchendorp, Rory D. de Vries, Carla C. Baan, Debbie van Baarle, Rob van Binnendijk, Dimitri A. Diavatopoulos, Daryl Geers, Katharina S. Schmitz, Corine H. GeurtsvanKessel, Gerco den Hartog, Marcia M. L. Kho, Marion P. G. Koopmans, Renate G. van der Molen, Ester B. M. Remmerswaal, Nynke Rots, Ron T. Gansevoort, Frederike J. Bemelman, Luuk B. Hilbrands, Marlies E. J. Reinders

Summary: The immune response to COVID-19 vaccination is inferior in kidney transplant recipients and to a lesser extent in patients on dialysis or with chronic kidney disease. The antibody levels and T-cell responses significantly decrease after 6 months of vaccination, and neutralization of the Omicron variant is barely detectable.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial

Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Froelke, Celine Imhof, Vera J. C. H. Koomen, S. Reshwan K. Malahe, Priya Vart, Daryl Geers, Rory D. de Vries, Corine H. Geurtsvan Kessel, Carla C. Baan, Renate G. van der Molen, Dimitri A. Diavatopoulos, Ester B. M. Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P. J. de Vries, Ron T. Gansevoort, Frederike J. Bemelman, Marlies E. J. Reinders, Jan-Stephan F. Sanders, Luuk B. Hilbrands

Summary: This study aimed to compare three alternative strategies for improving the COVID-19 vaccine response in kidney transplant recipients: double vaccine dose, heterologous vaccination, and temporary discontinuation of mycophenolate mofetil or mycophenolic acid. The results showed that repeated vaccination increased SARS-CoV-2-specific antibodies in kidney transplant recipients, but higher dose, heterologous vaccine, or discontinuation of immunosuppressants did not further enhance the response.

LANCET INFECTIOUS DISEASES (2023)

Editorial Material Medicine, General & Internal

Six pills less: no benefit for bicarbonate supplementation in renal allograft recipients

Klemens Budde, Fabian Halleck

LANCET (2023)

Article Transplantation

A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure

Manuel Mayrdorfer, Lutz Liefeldt, Bilgin Osmanodja, Marcel G. Naik, Danilo Schmidt, Wiebke Duettmann, Charlotte Hammett, Eva Schrezenmeier, Frank Friedersdorff, Kaiyin Wu, Fabian Halleck, Klemens Budde

Summary: This study analyzed 1477 adult kidney transplants and found that cardiovascular disease, malignancy, and infections were the most common causes of death. The study also discovered that there were many shared causes between death with a functioning graft and death-censored graft failure.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Transplantation

The 3-Step Model of informed consent for living kidney donation: a proposal on behalf of the DESCaRTES Working Group of the European Renal Association

Alessandra Agnese Grossi, Mehmet Sukru Sever, Rachel Hellemans, Christophe Mariat, Marta Crespo, Bruno Watschinger, Licia Peruzzi, Erol Demir, Arzu Velioglu, Ilaria Gandolfini, Gabriel C. Oniscu, Luuk Hilbrands, Geir Mjoen

Summary: Living donation challenges the ethical principle of non-maleficence as it involves exposing healthy individuals to risks for the sake of others. A proposed 3-S Model for standardized informed consent (IC) in living kidney donation emphasizes the importance of safety, education, and equitable decision-making. This model provides guidance for nephrologists and transplant clinicians concerning timing, content, communication of risks, and assessment of understanding prior to donation.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Pediatrics

Rejection markers in kidney transplantation: do new technologies help children?

Licia Peruzzi, Silvia Deaglio

Summary: Recent insights have revealed that the process of allorecognition and graft rejection in transplantation involves multiple pathways of both adaptive and innate immune response. Traditional markers for transplant monitoring, such as serum creatinine, proteinuria, and drug blood levels, are widely used due to their affordability and availability. Donor-specific antibodies, the most common immunological biomarkers, are included in routine post-transplant monitoring but have some reproducibility issues. New omic technologies have led to the identification of novel biomarkers, including urinary chemokines and cell-free DNA of donor origin, which show promise but are currently expensive. Transcriptomics, metabolomics, proteomics, and the study of extracellular vesicles also have the potential for early identification of rejection in a cost-effective manner. These new biomarkers are expected to integrate with traditional tools for improved rejection detection and timely intervention.

PEDIATRIC NEPHROLOGY (2023)

Review Urology & Nephrology

Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe-lessons for the future

Marlies Noordzij, Bjorn Meijers, Ron T. Gansevoort, Adrian Covic, Raphael Duivenvoorden, Luuk B. Hilbrands, Marc H. Hemmelder, Kitty J. Jager, Geir Mjoen, Ionut Nistor, Ekaterina Parshina, Giuseppina Pessolano, Serhan Tuglular, Priya Vart, Luca Zanoli, Casper F. M. Franssen, ERACODA collaborators

Summary: This study analyzed the infection prevention and control strategies implemented by dialysis centers in Europe during the first wave of the COVID-19 pandemic. The results showed that most centers implemented measures such as fever screening, hand disinfection, and mask-wearing to prevent the spread of the virus. There were variations between centers and national guidelines in terms of recommended distances between dialysis chairs and isolation practices.

CLINICAL KIDNEY JOURNAL (2023)

Article Multidisciplinary Sciences

When performance is not enough-A multidisciplinary view on clinical decision support

Roland Roller, Aljoscha Burchardt, David Samhammer, Simon Ronicke, Wiebke Duettmann, Sven Schmeier, Sebastian Moeller, Peter Dabrock, Klemens Budde, Manuel Mayrdorfer, Bilgin Osmanodja

Summary: This article discusses the application of machine learning models in healthcare and presents a multidisciplinary view of medical decision support systems. It covers information technology, medical, and ethical aspects and provides insights into implementing and evaluating these systems in a clinical setting.

PLOS ONE (2023)

Article Pharmacology & Pharmacy

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

Francois R. Girardin, Anna Nicolet, Oriol Bestard, Carmen Lefaucheur, Klemens Budde, Fabian Halleck, Sophie Brouard, Magali Giral, Pierre-Antoine Gourraud, Beatrice Horcholle, Jean Villard, Joachim Marti, Alexandre Loupy

Summary: This multi-center cohort study investigated the quality of life (QoL) of kidney transplant recipients during the first year after transplantation. Using EQ-5D and VAS data as measures, the study found that patients who maintained standard-of-care therapy had better QoL compared to those who switched therapies. These findings provide important insights for assessing the QoL of kidney transplant recipients.

FRONTIERS IN PHARMACOLOGY (2023)

Article Medicine, General & Internal

Pregnancy after Kidney Transplantation-Impact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity of Immunosuppression on Kidney Function and Maternal Health

Rebecca Kaatz, Elisabetta Latartara, Friederike Bachmann, Nils Lachmann, Nadine Koch, Bianca Zukunft, Kaiyin Wu, Danilo Schmidt, Fabian Halleck, Peter Nickel, Kai-Uwe Eckardt, Klemens Budde, Stefan Verlohren, Mira Choi

Summary: Women of childbearing age who have undergone kidney transplantation experience increased fertility, but are at risk for complications such as preeclampsia, preterm delivery, and allograft dysfunction. A retrospective study was conducted on 40 women who had post-transplant pregnancies between 2003 and 2019. The study found that the pregnancies had good outcomes for both the mothers and the transplanted kidneys, although there were declines in kidney function. Adverse pregnancy events, such as preeclampsia with severe end-organ dysfunction, were associated with impaired hyperfiltration during pregnancy and a decline in renal function. The frequency of de novo donor-specific antibodies did not increase after delivery.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Transplantation

Predictors of graft failure after first detection of de novo donor-specific HLA antibodies in kidney transplant recipients

Covadonga Lopez del Moral, Kaiyin Wu, Marcel Naik, Bilgin Osmanodja, Aylin Akifova, Nils Lachmann, Diana Stauch, Sabine Hergovits, Mira Choi, Friederike Bachmann, Fabian Halleck, Eva Schrezenmeier, Danilo Schmidt, Klemens Budde

Summary: This study found that renal function, proteinuria, and rejection are strongly associated with graft failure in patients with dnDSAs and may serve as surrogate endpoints.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Immunology

Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism

Hongfan Zhao, Dashan Wu, Michael Adu Gyamfi, Pinchao Wang, Christian Luecht, Anna Maria Pfefferkorn, Muhammad Imtiaz Ashraf, Julian Kamhieh-Milz, Janusz Witowski, Duska Dragun, Klemens Budde, Ralf Schindler, Daniel Zickler, Guido Moll, Rusan Catar

Summary: Expanded hemodialysis therapy with improved molecular cut-off dialyzers has beneficial effects in reducing uremia-associated chronic systemic microinflammation, which is a driver of endothelial dysfunction and cardiovascular disease in hemodialysis patients. The transcription factor KLF2 and its associated molecular signaling pathways are identified as key targets and regulators in uremia-induced endothelial microinflammation.

FRONTIERS IN IMMUNOLOGY (2023)

Article Surgery

Can We Predict Graft Intolerance Syndrome After Kidney Transplant Failure? External Validation of a Previously Developed Model

Kim Bunthof, Khalid Saboerali, Jacqueline Van De Wetering, Azam Nurmohamed, Frederike Bemelman, Arjan Van Zuilen, Jan Van Den Brand, Marije Baas, Luuk Hilbrands

Summary: This study aimed to validate a previously established prediction model for graft intolerance syndrome in an independent cohort. The validation cohort consisted of patients with late kidney graft failure between 2008 and 2018. The original model, which included donor age, graft survival, and number of acute rejections, performed poorly in the validation cohort. However, after retraining the model using recipient age at graft failure instead of donor age, it showed moderate performance in both the development and validation cohorts.

TRANSPLANT INTERNATIONAL (2023)

Article Urology & Nephrology

Sustained employment, work disability and work functioning in CKD patients: a cross-sectional survey study

Manna A. Alma, Sijrike F. van der Mei, Sandra Brouwer, Luuk B. Hilbrands, Paul J. M. van der Boog, Herma Uiterwijk, Femke Waanders, Maaike Hengst, Ron T. Gansevoort, Annemieke Visser

Summary: Kidney failure negatively impacts employment opportunities. Employed patients with chronic kidney disease face difficulties in work functioning, requiring adjustments or work disability benefits. Pre-emptive transplantation and good physical health contribute to sustained employment.

JOURNAL OF NEPHROLOGY (2023)

No Data Available